Theranostic 64Cu-DOTHA2-PSMA for metastatic prostate cancer treatment, a preclinical study

被引:0
|
作者
Milot, M. C. [1 ]
Benesty, O. Belissant [1 ]
Dumulon-Perreault, V. [2 ]
Ait-Mohand, S. [1 ]
Rousseau, E. [1 ]
Richard, P. [3 ]
Guerin, B. [1 ]
机构
[1] Univ Sherbrooke, Nucl Med & Radiobiol, Sherbrooke, PQ, Canada
[2] CRCHUS, Ctr Imagerie Mole Sherbrooke, Sherbrooke, PQ, Canada
[3] Univ Sherbrooke, Surg, Sherbrooke, PQ, Canada
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
56
引用
收藏
页码:S24 / S24
页数:1
相关论文
共 50 条
  • [31] Real-time diagnosis of sampled lesions in targeted biopsy of prostate Cancer using a novel tracer [64Cu] Cu-DOTA-PSMA-3Q: a pilot preclinical study
    Zhang, Jingfeng
    Niu, Shaoxi
    Liu, Yachao
    Zhang, Xiaojun
    Luan, Xiaohui
    Liu, Huanhuan
    Pan, Yue
    Xu, Xiaodan
    Wu, Shina
    Wang, Yuan
    Chen, Zhiqiang
    Wang, Baojun
    Zhang, Xu
    Wang, Ruimin
    Zhang, Jinming
    Xu, Baixuan
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2025, 52 (04) : 1257 - 1270
  • [32] Preclinical and clinical evaluation of [64Cu]Cu-PSMA-Q PET/CT for prostate cancer detection and its comparison with [18F]FDG imaging
    Fei Chen
    Hao Zhang
    Yousheng Zhan
    Xiaohong Huang
    Zongxi He
    Daiyuan Ma
    Tielong Tang
    Suping Li
    Scientific Reports, 15 (1)
  • [33] Preclinical and Clinical Status of PSMA-Targeted Alpha Therapy for Metastatic Castration-Resistant Prostate Cancer
    Juzeniene, Asta
    Stenberg, Vilde Yuli
    Bruland, Oyvind Sverre
    Larsen, Roy Hartvig
    CANCERS, 2021, 13 (04) : 1 - 25
  • [34] 64Cu-ATSM/64Cu-Cl2 and their relationship to hypoxia in glioblastoma: a preclinical study
    Elodie A. Pérès
    Jérôme Toutain
    Louis-Paul Paty
    Didier Divoux
    Méziane Ibazizène
    Stéphane Guillouet
    Louisa Barré
    Aurélien Vidal
    Michel Cherel
    Mickaël Bourgeois
    Myriam Bernaudin
    Samuel Valable
    EJNMMI Research, 9
  • [35] 64Cu-ATSM/64Cu-Cl2 and their relationship to hypoxia in glioblastoma: a preclinical study
    Peres, Elodie A.
    Toutain, Jerome
    Paty, Louis-Paul
    Divoux, Didier
    Ibazizene, Meziane
    Guillouet, Stephane
    Barre, Louisa
    Vidal, Aurelien
    Cherel, Michel
    Bourgeois, Mickael
    Bernaudin, Myriam
    Valable, Samuel
    EJNMMI RESEARCH, 2019, 9 (01)
  • [36] Combined Biology-Guided Radiotherapy and Lutetium PSMA Treatment in Metastatic Prostate Cancer
    Gaudreault, M.
    Chang, D.
    Hardcastle, N.
    Jackson, P.
    Kron, T.
    Hofman, M. S.
    Siva, S.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2022, 114 (03): : S116 - S116
  • [37] COMBAT: A study of 64Cu-SAR-BBN and 67Cu-SAR-BBN for identification and treatment of GRPr-expressing metastatic castrate resistant prostate cancer ineligible for therapy with 177Lu-PSMA-617
    Nordquist, Luke
    Lengyelova, Eva
    Almaguel, Frankis
    Mancini, Brandon
    Song, Hong
    Armstrong, Andrew
    Zurita, Amado
    Anderson, Monique
    Parker, Michelle
    Miller, Robert
    Iagaru, Andrei
    JOURNAL OF NUCLEAR MEDICINE, 2024, 65
  • [38] Development of [64Cu]Cu-NGUL and [67Cu]Cu-NGUL as a matched-pair theranostic for prostate cancer
    Seo, Hye Yeon
    Byun, Jung Woo
    Yoo, Ran Ji
    Park, Ji Yong
    Kim, Young Joo
    Kim, Kweon
    Lee, Kyo Chul
    Kim, Jung Young
    Park, Hyun
    Park, Jeong Hoon
    Jung, Jiyoon
    Lee, Myungsu
    Lee, Jooeun
    Jeong, Jae Min
    Lee, Yun-Sang
    NUCLEAR MEDICINE AND BIOLOGY, 2022, 114 : S61 - S61
  • [39] A Preclinical Study of an 125I-Labeled PSMA Ligand for Prostate-Cancer Puncture
    Luan, Xiaohui
    Zhou, Haoxi
    Chen, Yimin
    Zhang, Xiaojun
    Cui, Mengchao
    Chen, Kuang
    Xu, Xiaodan
    Zhang, Jinming
    Xu, Baixuan
    PHARMACEUTICALS, 2022, 15 (10)
  • [40] Preclinical Assessment of the Combination of PSMA-Targeting Radionuclide Therapy with PARP Inhibitors for Prostate Cancer Treatment
    Ruigrok, Eline A. M.
    Verkaik, Nicole S.
    de Blois, Erik
    de Ridder, Corrina
    Stuurman, Debra
    Roobol, Stefan J.
    Van Gent, Dik C.
    de Jong, Marion
    Van Weerden, Wytske M.
    Nonnekens, Julie
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (14)